Barbara Lovrencic: Amplifying the Patient Voice at the EMA – Shaping the Future of ITP Care
Barbara Lovrencic, Browser Creator and Developer Assistant, ERP Manager at A.z. solutions s.r.l., shared a post on LinkedIn:
“Grateful to have taken part in the EMA workshop ‘Challenges in Drug Development, Regulation and Clinical Practice in Immune Thrombocytopenia’ on 30 June, representing AIPIT and the patient community.
It was a privilege to share the patient perspective alongside leading clinicians, researchers and regulators from EMA, FDA, PMDA and Health Canada.
What struck me most was EMA’s genuine openness to listening — patients were not just invited to attend, but truly heard as part of the conversation shaping the future update of the clinical development guideline for ITP.
Thank you to Daniela Philadelphia, Caroline Voltz-Girolt and the entire Haematology Working Party for creating a space where the patient voice carries real weight.
Days like this are the proof why patient advocacy matters, and why dialogue between patients, clinicians and regulators is essential to better care for people living with ITP.”
Stay updated with Hemostasis Today.
-
Aug 25, 2026, 07:28Manuel Monreal: VTE and Severe Renal Insufficiency – What Does RIETE Tell Us?
-
Aug 25, 2026, 07:26Tom B.: Platelet Transfusion as a Potential Mitochondrial Therapy for Sepsis
-
Aug 25, 2026, 07:20Scott McInnes: Giving Blood When the Need Is Greater Than Ever
-
Aug 25, 2026, 06:10Shiny K. Kajal: Rh Is More Than Just Positive or Negative
-
Aug 25, 2026, 00:07Muhammad Ali Khan: Using EHR Data to Predict Fibrotic Progression in PV and ET
-
Aug 25, 2026, 00:06Michael R. Scoma: The Vascular Dimension of Long COVID
-
Aug 24, 2026, 23:40Vimee Bindra: Your Period May Be Trying to Tell You Something
-
Aug 24, 2026, 23:30R. P. Singh: Hemophilia and HIV Relationship
-
Aug 24, 2026, 23:12Marta Velia Antonini: Hemolysis in ECMO – More Than Just a Laboratory Finding